Literature DB >> 33677812

Challenges of CYP21A2 genotyping in children with 21-hydroxylase deficiency: determination of genotype-phenotype correlation using next generation sequencing in Southeastern Anatolia.

M Karaoğlan1, G Nacarkahya2, E H Aytaç3, M Keskin3.   

Abstract

BACKGROUND/
PURPOSE: Although it is known that there is generally a good correlation between genotypes and phenotypes, the number of studies reporting discrepancies has recently increased, exclusively between milder genotypes and their phenotypes due to the complex nature of the CYP21A2 gene and methodological pitfalls. This study aimed to assess CYP21A2 genotyping in children with 21-hydroxylase deficiency (21-OHD) and establish their predictive genotype-phenotype correlation features using a large cohort in Southeastern Anatolia's ethnically diverse population.
METHODS: The patients were classified into three groups: salt-wasting (SW), simple virilizing (SV) and non-classical (NC). The genotypes were categorized into six groups due to residual enzyme activity: null-A-B-C-D-E. CYP21A2 genotyping was performed by sequence-specific primer and sequenced with next generation sequencing (NGS), and the expected phenotypes were compared to the observed phenotypes.
RESULTS: A total of 118 unrelated children with 21-OHD were included in this study (61% SW, 24.5% SV and 14.5% NC). The pathogenic variants were found in 79.5% of 171 mutated alleles (60.2%, 22.2%, and 17.6% in SW, SV and NC, respectively). Patient distribution based on genotype groups was as follows: null-16.1%, A-41.4%, B-6.0%, C-14.4%, E-22%). In2G was the most common pathogenic variant (33.9% of all alleles) and the most common variant in the three phenotype groups (SW-38.8%, SV-22.2% and NC-23.3%). The total genotype-phenotype correlation was 81.5%. The correlations of the null and A groups were 100% and 76.1%, respectively, while it was lower in group B and poor in group C (71.4% and 23.5%, respectively).
CONCLUSION: This study revealed that the concordance rates of the severe genotypes with their phenotypes were good, while those of the milder genotypes were poor. The discrepancies could have resulted from the complex characteristics of 21-OHD genotyping and the limitations of using NGS alone without integrating with other comprehensive methods.
© 2021. Italian Society of Endocrinology (SIE).

Entities:  

Keywords:  CYP21A2 gene mutation; Challenges of matching mild genotype with phenotype; Genotype–phenotype discrepancy

Mesh:

Substances:

Year:  2021        PMID: 33677812     DOI: 10.1007/s40618-021-01546-z

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  15 in total

Review 1.  Review of Clinical Next-Generation Sequencing.

Authors:  Sophia Yohe; Bharat Thyagarajan
Journal:  Arch Pathol Lab Med       Date:  2017-08-07       Impact factor: 5.534

2.  A unique haplotype of RCCX copy number variation: from the clinics of congenital adrenal hyperplasia to evolutionary genetics.

Authors:  Márton Doleschall; Andrea Luczay; Klára Koncz; Kinga Hadzsiev; Éva Erhardt; Ágnes Szilágyi; Zoltán Doleschall; Krisztina Németh; Dóra Török; Zoltán Prohászka; Balázs Gereben; György Fekete; Edit Gláz; Péter Igaz; Márta Korbonits; Miklós Tóth; Károly Rácz; Attila Patócs
Journal:  Eur J Hum Genet       Date:  2017-04-12       Impact factor: 4.246

3.  CYP21A2 Gene Pathogenic Variants: A Multicenter Study on Genotype-Phenotype Correlation from a Portuguese Pediatric Cohort.

Authors:  Rita Santos-Silva; Rita Cardoso; Lurdes Lopes; Marcelo Fonseca; Filipa Espada; Lurdes Sampaio; Carla Brandão; Ana Antunes; Graciete Bragança; Raquel Coelho; Teresa Bernardo; Paula Vieira; Rita Morais; Ana Luísa Leite; Luís Ribeiro; Berta Carvalho; Ana Grangeia; Renata Oliveira; Maria João Oliveira; Vicente Rey; Joana Rosmaninho-Salgado; Bernardo Marques; Ana Margarida Garcia; Andreia Meireles; Joana Carvalho; Ana Sequeira; Alice Mirante; Teresa Borges
Journal:  Horm Res Paediatr       Date:  2019-03-19       Impact factor: 2.852

Review 4.  CYP21A2 mutation update: Comprehensive analysis of databases and published genetic variants.

Authors:  Leandro Simonetti; Carlos D Bruque; Cecilia S Fernández; Belén Benavides-Mori; Marisol Delea; Jorge E Kolomenski; Lucía D Espeche; Noemí D Buzzalino; Alejandro D Nadra; Liliana Dain
Journal:  Hum Mutat       Date:  2017-11-06       Impact factor: 4.878

5.  Comprehensive mutation analysis of the CYP21A2 gene: an efficient multistep approach to the molecular diagnosis of congenital adrenal hyperplasia.

Authors:  Zhi Xu; Wuyan Chen; Deborah P Merke; Nazli B McDonnell
Journal:  J Mol Diagn       Date:  2013-09-23       Impact factor: 5.568

6.  Issues with the Detection of Large Genomic Rearrangements in Molecular Diagnosis of 21-Hydroxylase Deficiency.

Authors:  Paola Concolino
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

7.  Steroid 21-hydroxylase deficiency: genotype may not predict phenotype.

Authors:  R C Wilson; A B Mercado; K C Cheng; M I New
Journal:  J Clin Endocrinol Metab       Date:  1995-08       Impact factor: 5.958

Review 8.  Congenital adrenal hyperplasia.

Authors:  Diala El-Maouche; Wiebke Arlt; Deborah P Merke
Journal:  Lancet       Date:  2017-05-30       Impact factor: 79.321

9.  EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency.

Authors:  Sabina Baumgartner-Parzer; Martina Witsch-Baumgartner; Wolfgang Hoeppner
Journal:  Eur J Hum Genet       Date:  2020-07-02       Impact factor: 4.246

10.  Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants

Authors:  Tülay Güran; Başak Tezel; Meltem Çakır; Ayşehan Akıncı; Zerrin Orbak; Mehmet Keskin; Beray Selver Eklioğlu; Alev Ozon; Mehmet Nuri Özbek; Gülay Karagüzel; Nihal Hatipoğlu; Fatih Gürbüz; Filiz Mine Çizmecioğlu; Cengiz Kara; Enver Şimşek; Firdevs Baş; Murat Aydın; Feyza Darendeliler
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-03-11
View more
  1 in total

Review 1.  Congenital adrenal hyperplasia, disorders of sex development, and infertility in patients with POR gene pathogenic variants: a systematic review of the literature.

Authors:  C Gusmano; R Cannarella; A Crafa; F Barbagallo; S La Vignera; R A Condorelli; A E Calogero
Journal:  J Endocrinol Invest       Date:  2022-07-17       Impact factor: 5.467

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.